Literature DB >> 11730971

Modelling of promiscuous receptor-Gi/Gs-protein coupling and effector response.

J P Kukkonen1, J Näsman, K E Akerman.   

Abstract

A single G-protein-coupled receptor might activate multiple G-protein species. This multiplex coupling ability can be used by tissues to regulate signalling; for the pharmacologist, such multiplex coupling might cause difficulties in the interpretation of experimental data. In this article, we present mathematical models for the activation of two separate G-protein species by a single receptor. Issues addressed concern mutual antagonism between the G proteins and the availability of an already activated receptor for interaction with a new G protein (receptor-G-protein-effector complexing versus free diffusion of G proteins) in addition to receptor-G-protein precoupling at different G-protein and receptor expression levels. The output from the receptor models uses, as readout, a new model for adenylyl cyclase regulation by two allosteric regulators (i.e. G(s) and G(i)).

Mesh:

Substances:

Year:  2001        PMID: 11730971     DOI: 10.1016/s0165-6147(00)01864-2

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  13 in total

1.  Modelling of the activation of G-protein coupled receptors: drug free constitutive receptor activity.

Authors:  P J Woodroffe; L J Bridge; J R King; C Y Chen; S J Hill
Journal:  J Math Biol       Date:  2009-04-05       Impact factor: 2.259

2.  Factors influencing biased agonism in recombinant cells expressing the human α1A -adrenoceptor.

Authors:  Edilson Dantas da Silva Junior; Masaaki Sato; Jon Merlin; Natalie Broxton; Dana S Hutchinson; Sabatino Ventura; Bronwyn A Evans; Roger J Summers
Journal:  Br J Pharmacol       Date:  2017-06-10       Impact factor: 8.739

3.  Cell contact-dependent functional selectivity of β2-adrenergic receptor ligands in stimulating cAMP accumulation and extracellular signal-regulated kinase phosphorylation.

Authors:  Ali I Kaya; H Ongun Onaran; Gülnihal Özcan; Caterina Ambrosio; Tommaso Costa; Sezen Balli; Özlem Ugur
Journal:  J Biol Chem       Date:  2012-01-12       Impact factor: 5.157

4.  Cholesterol-dependent separation of the beta2-adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction.

Authors:  Stéphanie M Pontier; Yann Percherancier; Ségolène Galandrin; Andreas Breit; Céline Galés; Michel Bouvier
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

5.  Scalable rule-based modelling of allosteric proteins and biochemical networks.

Authors:  Julien F Ollivier; Vahid Shahrezaei; Peter S Swain
Journal:  PLoS Comput Biol       Date:  2010-11-04       Impact factor: 4.475

6.  Succinate is a paracrine signal for liver damage.

Authors:  Paulo Renato A V Correa; Emma A Kruglov; Mayerson Thompson; M Fatima Leite; Jonathan A Dranoff; Michael H Nathanson
Journal:  J Hepatol       Date:  2007-04-05       Impact factor: 25.083

7.  Chapter 11. Subsecond analyses of G-protein coupled-receptor ternary complex dynamics by rapid mix flow cytometry.

Authors:  Tione Buranda; Yang Wu; Larry A Sklar
Journal:  Methods Enzymol       Date:  2009       Impact factor: 1.600

8.  Expression of striatal adenosine and dopamine receptors in mice deficient in the p50 subunit of NF-kappaB.

Authors:  Xiaobin Xie; Krishna A Jhaveri; Ming Ding; Larry F Hughes; Linda A Toth; Vickram Ramkumar
Journal:  Life Sci       Date:  2007-08-19       Impact factor: 5.037

9.  Nitric oxide signalling by selective beta(2)-adrenoceptor stimulation prevents ACh-induced inhibition of beta(2)-stimulated Ca(2+) current in cat atrial myocytes.

Authors:  Elena N Dedkova; Yong Gao Wang; Lothar A Blatter; Stephen L Lipsius
Journal:  J Physiol       Date:  2002-08-01       Impact factor: 5.182

10.  Effects of integrin-mediated cell adhesion on plasma membrane lipid raft components and signaling.

Authors:  Andrés Norambuena; Martin A Schwartz
Journal:  Mol Biol Cell       Date:  2011-07-27       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.